{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-23-004687","form_type":"8-K","ticker":"ACHV","cik":"0000949858","company_name":"ACHIEVE LIFE SCIENCES, INC.","filed_at":"2023-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.689345+00:00","generated_at":"2026-06-17T09:55:56.661230+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Achieve Life Sciences appoints three new directors; three incumbents not standing for reelection","bullets":["Stuart Duty, Thomas King, and Tom Sellig appointed to board effective March 29, 2023.","Donald Joseph, Martin Mattingly, and Jay Moyes will not stand for reelection at June 2023 annual meeting.","Appointments made under Cooperation Agreement with Dialectic Capital Management dated March 1, 2023.","New directors each receive pro-rata $40K annual retainer and initial option for 24,000 shares vesting over 3 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-23-004687","json":"https://secwatch.observer/filing/0001564590-23-004687.json","markdown":"https://secwatch.observer/filing/0001564590-23-004687.md","text":"https://secwatch.observer/filing/0001564590-23-004687.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/949858/000156459023004687/0001564590-23-004687-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/949858/000156459023004687/achv-8k_20230329.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T09:55:56.661230+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"017ad5bf15","claim":"Martin Mattingly departed as Director at ACHIEVE LIFE SCIENCES, INC..","evidence_excerpt":"Mr. Donald Joseph, Dr. Martin Mattingly and Mr. Jay Moyes (collectively, the “Outgoing Directors”), each a member of the Board, informed the Board that they would not be standing for reelection to the Board when their terms end at the Company’s 2023 annual meeting","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000156459023004687/0001564590-23-004687-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"Not standing for reelection"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"6ac0b63b8a","claim":"Jay Moyes departed as Director at ACHIEVE LIFE SCIENCES, INC..","evidence_excerpt":"Mr. Donald Joseph, Dr. Martin Mattingly and Mr. Jay Moyes (collectively, the “Outgoing Directors”), each a member of the Board, informed the Board that they would not be standing for reelection to the Board when their terms end at the Company’s 2023 annual meeting","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000156459023004687/0001564590-23-004687-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"Not standing for reelection"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c873d6fb5a","claim":"Donald Joseph departed as Director at ACHIEVE LIFE SCIENCES, INC..","evidence_excerpt":"Mr. Donald Joseph, Dr. Martin Mattingly and Mr. Jay Moyes (collectively, the “Outgoing Directors”), each a member of the Board, informed the Board that they would not be standing for reelection to the Board when their terms end at the Company’s 2023 annual meeting","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000156459023004687/0001564590-23-004687-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"Not standing for reelection"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}